跳至主要内容
临床试验/JPRN-jRCTs041180059
JPRN-jRCTs041180059招募中3 期

A randomized control trial of conditioning regimen of cord blood transplantation for adult myeloid malignancies comparing CA/CY/TBI with vs without G-CSF priming - G-CONCORD

Terakura Seitaro0 个研究点目标入组 108 人开始时间: 2019年2月28日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
108

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 16age old 至 <= 55age old(—)
性别
All

入选标准

  • 1.First stem cell transplantation including autologous or allogeneic.
  • 2.Hematological disease listed below.
  • -Acute myelogenous leukemia
  • -Myelodysplastic syndrome, RAEB-1 or RAEB-2. Either intermediate-II or high in IPSS. High or very-high in WPSS. Relapsed after CR.
  • 3.Obtained informed consent
  • 4.Performance status 0,1,2
  • 5.appropriate cord blood is available
  • 6.appropriate organ function

排除标准

  • 1.HBs antigen positive
  • 2.HCV antibody positive
  • 3.HIV antibody positive
  • 4 Donor-specific anti-HLA antibody positive
  • 5.Use of gemtuzumab ozogamicin within 6 months before transplantation
  • 6.During pregnant or breast-feeding
  • 7. Uncontrollable psychiatric disorder
  • 8. Uncontrollable infection
  • 9. Allergy for any drug used in the conditioning regimen or GVHD-prophylaxis
  • 10.Considered to be unfit for the study enrollment by the physician

研究者

发起方
Terakura Seitaro

相似试验